Physicians' awareness of gadolinium retention and MRI timing practices in the longitudinal management of pituitary tumors: a "Pituitary Society" survey.

导出 OA

翻译打印收藏纠错

作者： Lisa B,Nachtigall ^[1] ; Niki,Karavitaki ^[2] ; Katja,Kiseljak-Vassiliades ^[3] ; Luma,Ghalib ^[4] ; Hidenori,Fukuoka ^[5] ; Luis V,Syro ^[6] ; Daniel,Kelly ^[7] ; Maria,Fleseriu ^[8]

作者单位： Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School Boston, Boston, MA, USA. ^[1] Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, University of Birmingham, Birmingham, UK. ^[2] Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine at Colorado Anschutz Medical Campus, Aurora, CO, USA. ^[3] Division of Endocrinology, Ohio State University, Columbus, OH, USA. ^[4] Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe, Japan. ^[5] Department of Neurosurgery, Hospital Pablo Tobon Uribe and Clinica Medellin, Medellín, Colombia. ^[6] Pacific Neuroscience Institute & John Wayne Cancer Institute, Santa Monica, CA, USA. ^[7] Departments of Medicine and Neurological Surgery, Northwest Pituitary Center, Oregon Health & Science University, Mail Code: CH8N, 3303 SW Bond Ave., Portland, OR, 97239, USA. fleseriu@ohsu.edu. ^[8]

关键词 Adenoma Contrast Gadolinium Imaging Neuroendocrinologists Neurosurgeons Pituitary Safety Survey Tumor

主题词腺瘤(Adenoma);造影剂(Contrast Media);钆(Gadolinium);人类(Humans);磁共振成像(Magnetic Resonance Imaging);垂体肿瘤(Pituitary Neoplasms)

DOI 10.1007/s11102-018-0924-0

PMID 30456434

发布时间 2020-02-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交